Delivery Order SPE2DB24D2205-SPE2DB25FEFFP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,586.69 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price, non-set-aside contract was performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) with a ceiling value of $1,075.65. This competitive award, issued on July 21, 2025, represents a firm fixed-price delivery order with a completion date of July 22, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $4,175.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count units) on July 31, 2025, with completion expected by August 1, 2025. This is an unset-aside, competitively awarded contract with performance at the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,370.84 to AmerisourceBergen Drug Corp for Carvedilol ER 80 mg capsules (30-count) on August 15, 2025, with completion scheduled for August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $5,880.11 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply 4561919147 units of 20mg carvedilol ER capsules. Performance will take place in Conshohocken, Pennsylvania over one day, from August 23 to August 24, 2023. The delivery order was issued under DLA's Prime Vendor program, through which the agency obtains pharmaceuticals and other medical supplies for...
- The Defense Logistics Agency awarded a delivery order valued at $4,960.54 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count) on August 13, 2025, with completion scheduled for August 14, 2025. The contract employs firm fixed pricing and is not set-aside designated, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of Carvedilol ER 20 mg capsules. The contract has a ceiling value of $36,516.97 and a performance period through April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count packaging) with a ceiling value of $1,010.54 under a firm fixed price contract. This award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-set-aside competitive award to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- This is a $18,328.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of Carvedilol ER 40 mg capsules, which are critical pharmaceutical products used to support military treatment facilities and federal healthcare programs. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $60,710.25 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to supply 4561652691 carvedilol ER 40 mg capsules. Performance will take place in Conshohocken, Pennsylvania over one day in late July 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other medical supplies for troops; this...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFFPDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $15,723.03 for Carvedilol ER 40 mg capsules (30-count units). The contract, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, carries firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order falls under the company's comprehensive $999,999,999 IDC (SPE2DX) vehicle, which runs through December 2026 and serves as a global pharmaceutical support mechanism for military healthcare programs. The Defense Logistics Agency Medical Supply Chain utilizes AmerisourceBergen's prime vendor contract to fulfill pharmaceutical needs across the Department of Defense health system, including the Defense Health Agency and U.S. Coast Guard. Carvedilol, a beta-blocker used for cardiovascular disease management, represents the type of critical pharmaceutical commodity supplied through this vehicle to support military personnel and beneficiary healthcare requirements. This non-set-aside award demonstrates AmerisourceBergen's continued capability to compete for federal medical procurement on an open basis while maintaining its role as a key supplier within DLA's pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.7k | 7/22/25 |